Search results for: “clopidogrel”
-
CPIC® Guideline for Clopidogrel and CYP2C19
Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 update (January 2022) Updates since publication: None Tables in the main manuscript of the guideline: Table 1. Assignment of Predicted CYP2C19 Phenotype Based on Genotype Table 2. Antiplatelet therapy recommendations based on CYP2C19 phenotype when considering clopidogrel for cardiovascular…
-
CYP2C19 CPIC guidelines
CPIC guideline for clopidogrel based on CYP2C19 genotype CPIC guideline for voriconazole based on CYP2C19 genotype CPIC guideline for selective serotonin reuptake inhibitors based on CYP2D6 and CYP2C19 genotype CPIC guideline for tricyclic antidepressants based on CYP2D6 and CYP2C19 genotype CPIC guideline for proton pump inhibitors based on CYP2C19 genotype For gene-specific information tables (i.e.…
-
Prioritization of CPIC Guidelines
Prioritizing the order of writing guidelines for CPIC genes/drugs is based on the following criteria: CPIC guidelines published, in progress, or planned Gene – Drug Current CPIC level* Status TPMT, NUDT15 – thiopurines A Published; update in progress CYP2C19 – clopidogrel A Published CYP2C9,VKORC1, CYP4F2 – warfarin A Published CYP2D6 – opioids A Published HLA-B…